Prens EP - Search Results

1

Complement Activation in Inflammatory Skin Diseases.

Giang J, Seelen MAJ, van Doorn MBA, Rissmann R, Prens EP, Damman J. Giang J, et al. Among authors: prens ep. Front Immunol. 2018 Apr 16;9:639. doi: 10.3389/fimmu.2018.00639. eCollection 2018. Front Immunol. 2018. PMID: 29713318 Free PMC article. Review.

2

CD40 ligation-induced cytokine production in human skin explants is partly mediated via IL-1.

Companjen AR, van der Wel LI, Boon L, Prens EP, Laman JD. Companjen AR, et al. Among authors: prens ep. Int Immunol. 2002 Jun;14(6):669-76. doi: 10.1093/intimm/dxf033. Int Immunol. 2002. PMID: 12039918 Free article.

3

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.

van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E. van der Fits L, et al. Among authors: prens ep. J Immunol. 2009 May 1;182(9):5836-45. doi: 10.4049/jimmunol.0802999. J Immunol. 2009. PMID: 19380832

4

Monitoring antigen-specific biologics: current knowledge and future prospects.

Zandvliet ML, van Bezooijen JS, Bos MA, Prens EP, van Doorn M, Bijen I, Schreurs MW, van der Velden VH, Koch BC, van Gelder T. Zandvliet ML, et al. Among authors: prens ep. Ther Drug Monit. 2013 Oct;35(5):588-94. doi: 10.1097/FTD.0b013e318295f6b2. Ther Drug Monit. 2013. PMID: 23942545 Review.

5

[Medical indications for laser therapy in dermatology].

Prens SP, de Vries K, van Doorn MB, Prens EP. Prens SP, et al. Among authors: prens ep. Ned Tijdschr Geneeskd. 2013;157(44):A6662. Ned Tijdschr Geneeskd. 2013. PMID: 24168850 Dutch.

6

Combining biologics with methotrexate in psoriasis: a systematic review.

van Bezooijen JS, Prens EP, Pradeepti MS, Atiqi R, Schreurs MWJ, Koch BCP, van Gelder T, van Doorn MBA. van Bezooijen JS, et al. Among authors: prens ep. Br J Dermatol. 2015 Jun;172(6):1676-1680. doi: 10.1111/bjd.13573. Epub 2015 Apr 29. Br J Dermatol. 2015. PMID: 25470815 Review. No abstract available.

7

A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose.

Greveling K, de Vries K, van Doorn MB, Prens EP. Greveling K, et al. Among authors: prens ep. Br J Dermatol. 2016 May;174(5):1134-6. doi: 10.1111/bjd.14330. Epub 2016 Feb 11. Br J Dermatol. 2016. PMID: 26615810 No abstract available.

8

Recurrence rate of lentigo maligna after micrographically controlled staged surgical excision.

de Vries K, Greveling K, Prens LM, Munte K, Koljenović S, van Doorn MB, Prens EP. de Vries K, et al. Among authors: prens ep, prens lm. Br J Dermatol. 2016 Mar;174(3):588-93. doi: 10.1111/bjd.14325. Epub 2016 Jan 27. Br J Dermatol. 2016. PMID: 26616840

9

Injection site reactions after subcutaneous oligonucleotide therapy.

van Meer L, Moerland M, Gallagher J, van Doorn MB, Prens EP, Cohen AF, Rissmann R, Burggraaf J. van Meer L, et al. Among authors: prens ep. Br J Clin Pharmacol. 2016 Aug;82(2):340-51. doi: 10.1111/bcp.12961. Epub 2016 May 31. Br J Clin Pharmacol. 2016. PMID: 27061947 Free PMC article. Review.

10

Comparison of Three Assays to Quantify Infliximab, Adalimumab, and Etanercept Serum Concentrations.

van Bezooijen JS, Koch BC, van Doorn MB, Prens EP, van Gelder T, Schreurs MW. van Bezooijen JS, et al. Among authors: prens ep. Ther Drug Monit. 2016 Aug;38(4):432-8. doi: 10.1097/FTD.0000000000000310. Ther Drug Monit. 2016. PMID: 27120178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters